Johnson & Johnson posts Q3 profit plunge but raises full‑year 2026 outlook
Johnson & Johnson reported third‑quarter 2026 revenue of $25.4 billion, a 5.9% year‑over‑year increase, while GAAP earnings fell to $0.09 per share after a one‑time charge. Adjusted earnings were $2.59 per share, beating estimates. The company lifted its full‑year sales target to $101.2 billion and its adjusted EPS outlook to $11.05‑$11.15 per share. Despite the raised guidance, the stock slipped in pre‑market trading.
Why it matters
The company’s guidance lift expands the revenue target for 2026, which may affect analysts’ valuation models (the guidance lift is noted in the company’s filing). However, the sharp drop in GAAP profit and the pre‑market share decline signal investor concern over the one‑time litigation and acquisition charges (pre‑market decline reported in).
Key facts
- 1Q3 2026 reported sales were $25,399 million, up 5.9% YoY. marketscreener.com
- 2GAAP net earnings were $210 million, and diluted EPS was $0.09. marketscreener.com
- 3Adjusted EPS (non‑GAAP) was $2.59 per share, a 7.5% decline from the prior year. marketscreener.com
- 4Full‑year 2026 sales guidance was raised to $101.2 billion. marketscreener.com
- 5Full‑year 2026 adjusted EPS guidance was set at $11.05‑$11.15 per share. marketscreener.com
Summary written by AlphAI AI Desk from 20 of 72 sources. Not investment advice. Figures are as stated by the linked sources.